UPEXI INC (UPXI) Stock Price, Forecast & Analysis

USA Nasdaq NASDAQ:UPXI • US39959A2050

1.14 USD
+0.05 (+4.59%)
At close: Feb 6, 2026
1.14 USD
0 (0%)
Pre-Market: 2/9/2026, 8:32:45 AM

UPXI Key Statistics, Chart & Performance

Key Statistics
Market Cap72.06M
Revenue(TTM)20.69M
Net Income(TTM)54.69M
Shares63.21M
Float52.15M
52 Week High22.57
52 Week Low1.03
Yearly DividendN/A
Dividend Yield0%
EPS(TTM)-3.6
PEN/A
Fwd PEN/A
Earnings (Next)02-10
IPO2021-06-24
Sector
GICS SectorConsumer Staples
GICS IndustryPersonal Care Products
GICS IndustryGroupHousehold & Personal Products
GICS SubIndustryPersonal Care Products
UPXI short term performance overview.The bars show the price performance of UPXI in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months -20 -40 -60 -80

UPXI long term performance overview.The bars show the price performance of UPXI in the last 1, 2 and 3 years. 1 year 2 years 3 years -20 -40 -60 -80

The current stock price of UPXI is 1.14 USD. In the past month the price decreased by -48.88%. In the past year, price decreased by -70.92%.

UPEXI INC / UPXI Daily stock chart

UPXI Technical Analysis


Chartmill TA Rating
Chartmill Setup Rating

UPXI Fundamental Analysis

ChartMill assigns a fundamental rating of 4 / 10 to UPXI. UPXI has an average financial health and profitability rating.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

UPXI Financial Highlights

Over the last trailing twelve months UPXI reported a non-GAAP Earnings per Share(EPS) of -3.6. The EPS increased by 82.7% compared to the year before.


Industry RankSector Rank
PM (TTM) 264.27%
ROA 13.03%
ROE 25.94%
Debt/Equity 0.92
Chartmill High Growth Momentum
EPS Q2Q%148.99%
Sales Q2Q%112.1%
EPS 1Y (TTM)82.7%
Revenue 1Y (TTM)-31.83%

UPXI Forecast & Estimates

8 analysts have analysed UPXI and the average price target is 7.14 USD. This implies a price increase of 526.32% is expected in the next year compared to the current price of 1.14.

For the next year, analysts expect an EPS growth of 126.09% and a revenue growth 143.74% for UPXI


Analysts
Analysts82.5
Price Target7.14 (526.32%)
EPS Next Y126.09%
Revenue Next Year143.74%

UPXI Ownership

Ownership
Inst Owners24.65%
Ins Owners8.93%
Short Float %19.87%
Short Ratio2.53

UPXI Competitors/Peers

The largest stocks on the US markets in the "Personal Care Products" sub-industry
Full List
SymbolCompany NameTechnical RatingFundamental RatingFPEMarket Cap
EL ESTEE LAUDER COMPANIES-CL A32.2835.845B
KVUE KENVUE INC16.0834.733B
ELF ELF BEAUTY INC22.994.879B
IPAR INTERPARFUMS INC20.323.282B
BRBR BELLRING BRANDS INC8.652.336B
COTY COTY INC-CL A5.372.326B
OLPX OLAPLEX HOLDINGS INC15.181.001B
EPC EDGEWELL PERSONAL CARE CO8.79964.045M
BNKK BONK INC N/A741.92M
NUS NU SKIN ENTERPRISES INC - A7.54526.987M

About UPXI

Company Profile

UPXI logo image Upexi, Inc. engages in the development, manufacturing, and distribution of consumer products through direct-to-consumer network, wholesale partnerships, and major third-party platforms like Amazon. The company is headquartered in Tampa, Florida and currently employs 59 full-time employees. The company went IPO on 2021-06-24. The firm is a brand owner specializing in the development, manufacturing and distribution of consumer products with diversification into the cryptocurrency space. The Company’s brands include Lucky Tail, PRAX, and Cure Mushrooms. Lucky Tail is a pet care product brand that provides products from grooming tools to nutritional products. Cure Mushrooms is a full line of medicinal mushroom products, designed by effect for consumers, which offers mushroom extracts in tinctures and gummies. PRAX is a full line of medicinal mushroom products, designed by effect for consumers, which are cultivated, extracted, and produced in the United States. Its products are distributed in the United States of America and internationally through multiple entities and managed through locations in Florida.

Company Info

UPEXI INC

3030 Rocky Point Drive, Suite 420

Tampa FLORIDA US

Employees: 59

UPXI Company Website

UPXI Investor Relations

Phone: 17013535425

UPEXI INC / UPXI FAQ

Can you describe the business of UPEXI INC?

Upexi, Inc. engages in the development, manufacturing, and distribution of consumer products through direct-to-consumer network, wholesale partnerships, and major third-party platforms like Amazon. The company is headquartered in Tampa, Florida and currently employs 59 full-time employees. The company went IPO on 2021-06-24. The firm is a brand owner specializing in the development, manufacturing and distribution of consumer products with diversification into the cryptocurrency space. The Company’s brands include Lucky Tail, PRAX, and Cure Mushrooms. Lucky Tail is a pet care product brand that provides products from grooming tools to nutritional products. Cure Mushrooms is a full line of medicinal mushroom products, designed by effect for consumers, which offers mushroom extracts in tinctures and gummies. PRAX is a full line of medicinal mushroom products, designed by effect for consumers, which are cultivated, extracted, and produced in the United States. Its products are distributed in the United States of America and internationally through multiple entities and managed through locations in Florida.


Can you provide the latest stock price for UPEXI INC?

The current stock price of UPXI is 1.14 USD. The price increased by 4.59% in the last trading session.


Does UPEXI INC pay dividends?

UPXI does not pay a dividend.


What is the ChartMill technical and fundamental rating of UPXI stock?

UPXI has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 4 out of 10.


Is UPEXI INC (UPXI) expected to grow?

The Revenue of UPEXI INC (UPXI) is expected to grow by 143.74% in the next year. Check the estimates tab for more information on the EPS, Sales, EBIT and EBITDA future analyst estimates.


Can you provide the ownership details for UPXI stock?

You can find the ownership structure of UPEXI INC (UPXI) on the Ownership tab.